Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Villefranche sur Saône – page 4

45 clinical trials in Villefranche sur Saône, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Villefranche sur Saône at a glance
45
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

45 trials in Villefranche sur Saône

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ceralasertib
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Brigatinib
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Unicancer
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Amgen Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Villefranche sur Saône

What the registry says about research in the country

01 Lung Cancer Research

Extensive research focusing on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.

  • Advanced NSCLC Treatments
  • Immunotherapy Combinations
  • Targeted Therapies

Multiple trials exploring innovative treatment strategies for both early-stage and metastatic disease.

02 Gastrointestinal Oncology

Studies investigating treatments for colorectal cancer and gastroesophageal cancers, with particular focus on targeted therapies and combination approaches.

  • Advanced Colorectal Cancer
  • Gastric Cancer Treatments
  • Novel Drug Combinations

Research emphasizing personalized treatment approaches based on specific genetic mutations.

03 Other Medical Conditions

Diverse research portfolio including studies on nephrotic syndrome and severe asthma, evaluating new treatment protocols and medication management strategies.

  • Minimal Change Disease
  • Severe Allergic Asthma
  • Treatment Optimization

Focus on improving patient outcomes through innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.